Drug application
SODIUM PHOSPHATES IN PLASTIC CONTAINER (SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE)
Drugs@FDA NDA 018892 · HOSPIRA
Key facts
| Drug name | SODIUM PHOSPHATES IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Application type | NDA |
| Application number | 018892 |
| Company | HOSPIRA |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | May 10, 1983 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: